Royal Pharm Rg

Royalty Pharma plc buys biopharma royalties and funds innovation in the U.S., holding rights to ~35 marketed therapies and 14 development-stage candidates across rare disease, cancer, neuroscience, infectious disease, hematology and diabetes.

Headquarters: United States (USA)

Royal Pharm Rg Logo
Company Profile
  • HQ: New York
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
RPRX Royal Pharm Rg -Class A
Cap: 23.4B | P/E: 23.0
EQUITY NMS USD GB00BMVP7Y09 Active
📈
Home Login